Antimalarial drugs are an urgently need and crucial tool in the campaign against malaria, which can threaten public health. In this study, we examined the cytotoxicity of the 9 antimalarial compounds chemically synthesized using SKM13-2HCl. Except for SKM13-2HCl, the 5 newly synthesized compounds had a 50% cytotoxic concentration (CC50) > 100 µM, indicating that they would be less cytotoxic than SKM13-2HCl. Among the 5 compounds, only SAM13-2HCl outperformed SKM13-2HCl for antimalarial activity, showing a 3- and 1.3-fold greater selective index (SI) (CC50/IC50) than SKM13-2HCl in vitro against both chloroquine-sensitive (3D7) and chloroquine -resistant (K1) Plasmodium falciparum strains, respectively. Thus, the presence of morpholine amide may help to effectively suppress human-infectious P. falciparum parasites. However, the antimalarial activity of SAM13-2HCl was inferior to that of the SKM13-2HCl template compound in the P. berghei NK65-infected mouse model, possibly because SAM13-2HCl had a lower polarity and less efficient pharmacokinetics than SKM13-2HCl. SAM13-2HCl was more toxic in the rodent model. Consequently, SAM13-2HCl containing morpholine was selected from screening a combination of pharmacologically significant structures as being the most effective in vitro against human-infectious P. falciparum but was less efficient in vivo in a P. berghei-infected animal model when compared with SKM13-2HCl. Therefore, SAM13-2HCl containing morpholine could be considered a promising compound to treat chloroquine-resistant P. falciparum infections, although further optimization is crucial to maintain antimalarial activity while reducing toxicity in animals.
Citations
Citations to this article as recorded by
The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery Glory Adebayo, Opeyemi I. Ayanda, Matthias Rottmann, Olusola S. Ajibaye, Gbolahan Oduselu, Julius Mulindwa, Olayinka O. Ajani, Oluwagbemiga Aina, Pascal Mäser, Ezekiel Adebiyi Pharmaceuticals.2025; 18(3): 424. CrossRef
Structural, electrochemical and theoretical studies of some carboxamides David Izuchukwu Ugwu, Nandisiwe GS Mateyise, Jeanet Conradie Journal of Molecular Structure.2025; 1348: 143454. CrossRef
Antimalarial drugs play an important role in the control and treatment of malaria, a deadly disease caused by the protozoan parasite Plasmodium spp. The development of novel antimalarial agents effective against drug-resistant malarial parasites is urgently needed. The novel derivatives, SKM13-MeO and SKM13-F, were designed based on an SKM13 template by replacing the phenyl group with electron-donating (-OMe) or electron-withdrawing groups (-F), respectively, to reverse the electron density. A colorimetric assay was used to quantify cytotoxicity, and in vitro inhibition assays were performed on 3 different blood stages (ring, trophozoite, and schizonts) of P. falciparum 3D7 and the ring/mixed stage of D6 strain after synchronization. The in vitro cytotoxicity analysis showed that 2 new SKM13 derivatives reduced the cytotoxicity of the SKM13 template. SKM13 maintained the IC50 at the ring and trophozoite stages but not at the schizont stage. The IC50 values for both the trophozoite stage of P. falciparum 3D7 and ring/mixed stages of D6 demonstrated that 2 SKM13 derivatives had decreased antimalarial efficacy, particularly for the SKM13-F derivative. SKM13 may be comparably effective in ring and trophozoite, and electron-donating groups (-OMe) may be better maintain the antimalarial activity than electron-withdrawing groups (-F) in SKM13 modification.
Citations
Citations to this article as recorded by
Design, Synthesis and in vitro Evaluation of Primaquine and Diaminoquinazoline Hybrid Molecules Against the Malaria Parasite Mukul Kore, Anjani G. Rao, Dimple Acharya, Shrikant S. Kirwale, Amritansh Bhanot, Abhishek Govekar, Ajeet Kumar Mohanty, Aniruddha Roy, Shruthi S. Vembar, Sandeep Sundriyal Chemistry – An Asian Journal.2025;[Epub] CrossRef
Evaluation of the antimalarial activity of SAM13-2HCl with morpholine amide (SKM13 derivative) against antimalarial drug-resistant Plasmodium falciparum and Plasmodium berghei infected ICR mice Hyelee Hong, Kwonmo Moon, Thuy-Tien Thi Trinh, Tae-Hui Eom, Hyun Park, Hak Sung Kim, Seon-Ju Yeo Parasites, Hosts and Diseases.2024; 62(1): 42. CrossRef
Plasmodium lactate dehydrogenase (pLDH) is a strong target antigen for the determination of infection with Plasmodium species specifically. However, a more effective antibody is needed because of the low sensitivity of the current antibody in many immunological diagnostic assays. In this study, recombinant Plasmodium vivax LDH (PvLDH) was experimentally constructed and expressed as a native antigen to develop an effective P. vivax-specific monoclonal antibody (mAb). Two mAbs (2CF5 and 1G10) were tested using ELISA and immunofluorescence assays (IFA), as both demonstrated reactivity against pLDH antigen. Of the 2 antibodies, 2CF5 was not able to detect P. falciparum, suggesting that it might possess P. vivax-specificity. The detection limit for a pair of 2 mAbs-linked sandwich ELISA was 31.3 ng/ml of the recombinant antigen. The P. vivax-specific performance of mAbs-linked ELISA was confirmed by in vitro-cultured P. falciparum and P. vivax-infected patient blood samples. In conclusion, the 2 new antibodies possessed the potential to detect P. vivax and will be useful in immunoassay.
Citations
Citations to this article as recorded by
Diagnostic Methods for Non-Falciparum Malaria Alba Marina Gimenez, Rodolfo F. Marques, Matías Regiart, Daniel Youssef Bargieri Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Plasmodium falciparum Parasitemia and Band Sensitivity of the SD Bioline Malaria Ag P.f/Pan Rapid Diagnostic Test in Madagascar Rajeev K. Mehlotra, Rosalind E. Howes, Estee Y. Cramer, Riley E. Tedrow, Tovonahary A. Rakotomanga, Stéphanie Ramboarina, Arsène C. Ratsimbasoa, Peter A. Zimmerman
The American Journal of Tropical Medicine and Hygiene.2019; 100(5): 1196. CrossRef
Toxoplasma gondii is an important opportunistic pathogen that causes toxoplasmosis, which has very few therapeutic treatment options. The most effective therapy is a combination of pyrimethamine and sulfadiazine; however, their utility is limited because of drug toxicity and serious side effects. For these reasons, new drugs with lower toxicity are urgently needed. In this study, the compound, (Z)-1-[(5-nitrofuran-2-yl)methyleneamino]-imidazolidine-2,4-dione (nitrofurantoin), showed anti-T. gondii effects in vitro and in vivo. In HeLa cells, the selectivity of nitrofurantoin was 2.3, which was greater than that of pyrimethamine (0.9). In T. gondii-infected female ICR mice, the inhibition rate of T. gondii growth in the peritoneal cavity was 44.7% compared to the negative control group after 4-day treatment with 100 mg/kg of nitrofurantoin. In addition, hematology indicators showed that T. gondii infection-induced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, biochemical parameters involved in liver injury, were reduced by nitrofurantoin significantly. Moreover, nitrofurantoin exerted significant effects on the index of antioxidant status, i.e., malondialdehyde (MDA) and glutathione (GSH). The nitrofurantoin-treated group inhibited the T. gondii-induced MDA levels while alleviating the decrease in GSH levels. Thus, nitrofurantoin is a potential anti-T. gondii candidate for clinical application.
Citations
Citations to this article as recorded by
Extracts of food and medicinal plants sold in Moroccan markets induce apoptosis-like in Toxoplasma gondii tachyzoites in vitro Ismail Elkoraichi, Nathalie Moiré, Samira Rais, Isabelle Dimier-Poisson, Fouad Daoudi, Françoise Debierre-Grockiego Scientific African.2025; 27: e02529. CrossRef
Efficacy of nitrofurantoin in treatment of murine model of trichinellosis Basma M. Elmansory, Hager S. Zoghroban, Dina M. El-Guindy, Dina A. El-Guindy Experimental Parasitology.2025; 277: 109022. CrossRef
The Brazilian Toxoplasma gondii strain BRI caused greater inflammation and impairment in anxiogenic behavior in mice, which was reverted by rosuvastatin treatment Fernanda Ferreira Evangelista, Priscilla de Laet Sant’Ana, Willian Costa Ferreira, Thaisa Andreia Ferreira, Milena Lopes dos Santos, Amanda Hinobu de Souza, Felipe Aparecido Lacerda de Andrade, Douglas Aparecido da Silva, Luiz Daniel de Barros, Cristiane Parasitology Research.2024;[Epub] CrossRef
Inclusion of Nitrofurantoin into the Realm of Cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing Perihan A. Elzahhar, Hisham A. Nematalla, Houssam Al-Koussa, Carla Abrahamian, Amira F. El-Yazbi, Larry Bodgi, Jolie Bou-Gharios, Joyce Azzi, Joelle Al Choboq, Hala F. Labib, Wassim Abou Kheir, Marwa M. Abu-Serie, Mohamed A. Elrewiny, Ahmed F. El-Yazbi, A Journal of Medicinal Chemistry.2023; 66(7): 4565. CrossRef
Evaluation of mono and combined nitrofurantoin therapy for toxoplasmosis
in vivo
using murine model
Asmaa Elkholy, Rita Wassef, Omnia Alsaid, Mona Elawady, Ashraf Barakat, Ashraf Soror, Shereen Kishik Pathogens and Global Health.2023; 117(7): 664. CrossRef
Old Dogs with New Tricks: Antiparasitic Potential of Structurally Diverse 5-Nitrofuran and 5-Nitrothiophene Imines and Acyl Hydrazones Ibrahim S. Al Nasr, Waleed S. Koko, Tariq A. Khan, Rainer Schobert, Bernhard Biersack Scientia Pharmaceutica.2023; 91(3): 44. CrossRef
Anti-Toxoplasma gondii agent isolated from Orostachys malacophylla (Pallas) Fischer Yan Piao, Lili Jin, Xu Cheng, Weifeng Yan, Changhao Zhang, Sihong Wang, Chunmei Jin Experimental Parasitology.2022; 242: 108397. CrossRef
Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs Christina Kannigadu, David. D. N'Da Current Pharmaceutical Design.2020; 26(36): 4658. CrossRef
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites Roberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, Patricia Vázquez, Luis Miguel Ferrer, Javier Blanco-Murcia, Javier Regidor-Cerrillo, Manuel Pizarro Díaz, Marta González-Huecas, Enrique Tabanera, Paula García-Lunar, Julio Benavides, Pablo Castaño, Andr International Journal for Parasitology: Drugs and Drug Resistance.2018; 8(1): 112. CrossRef
A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016) Mahbobeh Montazeri, Mehdi Sharif, Shahabeddin Sarvi, Saeed Mehrzadi, Ehsan Ahmadpour, Ahmad Daryani Frontiers in Microbiology.2017;[Epub] CrossRef
Lectins from Synadenium carinatum (ScLL) and Artocarpus heterophyllus (ArtinM) Are Able to Induce Beneficial Immunomodulatory Effects in a Murine Model for Treatment of Toxoplasma gondii Infection Eliézer L. P. Ramos, Silas S. Santana, Murilo V. Silva, Fernanda M. Santiago, Tiago W. P. Mineo, José R. Mineo Frontiers in Cellular and Infection Microbiology.2016;[Epub] CrossRef
After invasion of red blood cells, malaria matures within the cell by degrading hemoglobin avidly. For enormous protein breakdown in trophozoite stage, many efficient and ordered proteolysis networks have been postulated and exploited. In this study, a potential interaction of a 60-kDa Plasmodium falciparum (Pf)-heat shock protein (Hsp60) and Pf-calpain, a cysteine protease, was explored. Pf-infected RBC was isolated and the endogenous Pf-Hsp60 and Pf-calpain were determined by western blot analysis and similar antigenicity of GroEL and Pf-Hsp60 was determined with anti-Pf-Hsp60. Potential interaction of Pf-calpain and Pf-Hsp60 was determined by immunoprecipitation and immunofluorescence assay. Mizoribine, a well-known inhibitor of Hsp60, attenuated both Pf-calpain enzyme activity as well as P. falciparum growth. The presented data suggest that the Pf-Hsp60 may function on Pf-calpain in a part of networks during malaria growth.
Citations
Citations to this article as recorded by
To explore molecular targets and combination antimalarial chemotherapeutics as tissue and erythrocytic schizonticides Shilpa Mandal, Nehadrita Chattoraj, Sisir Nandi, Asmita Samadder Journal of Parasitic Diseases.2025;[Epub] CrossRef
Controlling drug resistance by targeting
Plasmodium falciparum
heat shock protein 70-1, a chaperone at the centre of protein quality control mechanism: a review
Douglas A. M. Ruhwaya, Brilliant Nyathi, Gadzikano Munyuki, Ryman Shoko, Grace Mugumbate All Life.2023;[Epub] CrossRef
Development of a Rapid Fluorescent Diagnostic System to Detect Subtype H9 Influenza A Virus in Chicken Feces Hien Thi Tuong, Ju Hwan Jeong, Young Ki Choi, Hyun Park, Yun Hee Baek, Seon-Ju Yeo International Journal of Molecular Sciences.2021; 22(16): 8823. CrossRef
Small Molecule Inhibitors Targeting the Heat Shock Protein System of Human Obligate Protozoan Parasites Tawanda Zininga, Addmore Shonhai International Journal of Molecular Sciences.2019; 20(23): 5930. CrossRef
Development of a Rapid Fluorescent Immunochromatographic Test to Detect Respiratory Syncytial Virus Trinh Thi Thuy Tien, Hyun Park, Hien Thi Tuong, Seung-Taek Yu, Du-Young Choi, Seon-Ju Yeo International Journal of Molecular Sciences.2018; 19(10): 3013. CrossRef
Rapid detection of avian influenza A virus by immunochromatographic test using a novel fluorescent dye Seon-Ju Yeo, Bui Thi Cuc, Soon-Ai Kim, Do Thi Hoang Kim, Duong Tuan Bao, Trinh Thi Thuy Tien, Nguyen Thi Viet Anh, Do-Young Choi, Chom-Kyu Chong, Hak Sung Kim, Hyun Park Biosensors and Bioelectronics.2017; 94: 677. CrossRef
Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles Seon-Ju Yeo, Duong Tuan Bao, Ga-Eun Seo, Cuc Thi Bui, Do Thi Hoang Kim, Nguyen Thi Viet Anh, Trinh Thi Thuy Tien, Nguyen Thi Phuong Linh, Hae-Jin Sohn, Chom-Kyu Chong, Ho-Joon Shin, Hyun Park Scientific Reports.2017;[Epub] CrossRef
First
Prev
